JANE HADINGER: Open Payments
NPI 1629158589 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 33 payments from 13 companies in 2025. Trend: 2023 $965 · 2024 $1,147 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| GlaxoSmithKline, LLC. | 7 | $163 |
| PFIZER INC. | 4 | $76 |
| Gilead Sciences, Inc. | 2 | $60 |
| SANOFI PASTEUR INC. | 2 | $49 |
| Novo Nordisk Inc | 2 | $42 |
| SHIELD THERAPEUTICS INC | 1 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Amgen Inc. | 1 | $24 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, NURTEC ODT, BEXSERO, BREZTRI, ACCRUFER, FARXIGA, AREXVY.
Industry payments across CA — which companies pay providers there.
